HS830 · Unit 6

HS830 Unit 6 counterargument memo example

Advanced Health Issues and Trends Purdue University Global Free custom sample in 24 to 48h

Hospital-onset infections from seven resistant pathogens rose about 20 percent during the pandemic, CDC reported in 2024, and stayed above prior levels through 2022. Arguing that the rise will last is easy. The HS830 Unit 6 counterargument memo instead builds the best case that it will not, a pandemic cycle already unwinding, and answers it on the evidence.

What this page holds

A composite system's quality chief receives this HS830 Unit 6 counterargument memo, which gives the pandemic-cycle reading of rising resistant infections its strongest form before replying. Searches like "hs 830 unit 6 assignment example", "hs830 unit 6 sample" and "hs830 unit 6 example" land here.

What a finished HS830 Unit 6 counterargument memo looks like

Four pages in memo format. First comes the writer's earlier claim, restated briefly: resistant hospital-onset infections have shifted upward durably and justify permanent stewardship staffing. The opposing reading then gets two full pages, stronger than its usual advocates make it: antibiotic use jumped in early COVID-19 care, infection prevention staff were redeployed, patients were sicker and carried more devices, and each of those conditions has eased, so rates should fall back. The memo supplies that reading's best evidence, including the steep fall in hospital MRSA bloodstream infections after the mid-2000s, proof that these rates respond to practice. A single page replies. It concedes that pandemic conditions explain most of the rise, notes that 2022 was still disrupted, and names the deciding indicator. A final paragraph separates incidence from the antibiotic market.

How a HS830 Unit 6 example is structured

Proportion is the argument. Giving the opposing reading twice the space of the reply is deliberate, because this unit usually scores whether the strongest objection was engaged, and a strong objection needs room for its mechanism and evidence. The memo builds that case from sources the writer would otherwise cite, which prevents a caricature. The reply refuses to overclaim. It does not say the cycle reading is wrong; it says the evidence cannot yet distinguish a cycle from a shift, since the last full year reported was itself unusual, and it moves the decision to a specific indicator and a date. The final paragraph addresses a confusion common in resistance debates: rising or falling infection counts say nothing about whether companies can profit from new antibiotics, and a paper that treats the two as one claim fails both.

The claim under challenge

Durable rise, permanent staffing: the writer's own position in three sentences, stated firmly enough that the counterargument has something solid to push against.

The cycle reading at full strength

Pandemic antibiotic prescribing, redeployed infection preventionists, device-heavy critical care and delayed routine surveillance, each tied to a source and a date, and each shown to be receding.

Precedent for reversion

Hospital MRSA bloodstream infections fell sharply from the mid-2000s once prevention bundles spread, which the memo places on the opposing side as proof that these rates answer to practice.

The reply: not yet decidable

Pandemic conditions explain most of the increase, 2022 was not a normal year, and NHSN data for 2023 and 2024 will decide it. Staffing is recommended as a two-year commitment reviewed against that series.

A separate problem

Achaogen won approval for plazomicin in 2018 and filed for bankruptcy in 2019. Market failure in antibiotic development persists regardless of incidence, and the memo keeps that claim apart.

Where marks go in HS830 Unit 6

Engaging the weakest objection is the defining failure of this genre, and graders at doctoral level check for it directly. A counterargument of the form 'some say resistance is overstated' earns almost nothing. The opposing case should be built from its best evidence, with a mechanism, and should be strong enough that a reader could briefly believe it. Concession is scored as a strength when it is specific: which part of the rise the cycle explains, stated plainly. Replies that simply restate the original claim more loudly read as unexamined. Strong memos convert the dispute into an indicator and a date. Conflating resistant infection rates with the economics of antibiotic development is a frequent error that costs marks for precision. Figures need their reporting years, since CDC updates these estimates periodically.

Get a HS830 Unit 6 example written to your instructions

A counterargument memo needs a claim to attack, ideally one of your own from an earlier unit. Paste it in with the Unit 6 prompt and rubric. Expect the opposing reading at its strongest, concessions wherever the evidence forces them, and a dispute reduced to one indicator and a date. First custom samples are free of charge; delivery takes 24-48h.

HS830 Unit 6 questions, answered

How much space should the opposing view get?

More than feels comfortable. The sample gives it twice the space of the reply, because a strong objection needs its mechanism and evidence laid out before it can be answered. If your rubric sets proportions, follow them; otherwise, aim for a version that someone holding the opposing view would recognize as their best argument.

What if the counterargument turns out to be right?

Then say so and revise. A memo that concludes the opposing reading is stronger is a legitimate outcome and often a high-scoring one, because it shows the analysis governed the conclusion. Most cases fall between: the objection explains part of the pattern, and the memo narrows the original claim to the part that survives.

Where do US resistance figures come from?

CDC's Antibiotic Resistance Threats Report and its later updates, built largely on the National Healthcare Safety Network, which hospitals report into. The sample cites the 2019 report for baseline burden and the 2024 update for pandemic-era change, and it dates each figure because estimation methods and reporting coverage have changed between editions.